4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000190
Chairperson & CEO sold 9,500 shares at an average $587.74 ($5,583,501)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
16 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-11-16 | Sale : show line 2 in the form 10b5-1 | −110 | $580.25 | $63,828 | 333,833 | I |
| 2026-11-16 | Sale : show line 3 in the form 10b5-1 | −170 | $581.25 | $98,813 | 333,663 | I |
| 2026-11-16 | Sale : show line 4 in the form 10b5-1 | −280 | $582.18 | $163,010 | 333,383 | I |
| 2026-11-16 | Sale : show line 5 in the form 10b5-1 | −240 | $583.61 | $140,066 | 333,143 | I |
| 2026-11-16 | Sale : show line 6 in the form 10b5-1 | −640 | $584.54 | $374,104 | 332,503 | I |
| 2026-11-16 | Sale : show line 7 in the form 10b5-1 | −1,382 | $585.83 | $809,621 | 331,121 | I |
| 2026-11-16 | Sale : show line 8 in the form 10b5-1 | −2,108 | $586.72 | $1,236,796 | 329,013 | I |
| Open-market sales · 9,500 sh · avg $587.74 · $5,583,501 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2026-11-16 | Exercise or conversion : show line 17 in the form 10b5-1 Stock Option | −9,500 | $117.76 | 2027-03-15 | 9,500 | 14,910 | I |
Loading xslF345X06/primarydocument.xml…